Scarica l'app Stockscreener
48.33
0.77%
0.37
Dopo l'orario di chiusura:
48.37
0.04
+0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Precedente Chiudi:
$47.96
Aprire:
$48.59
Volume 24 ore:
19.01M
Relative Volume:
0.46
Capitalizzazione di mercato:
$10.52B
Reddito:
$1.78B
Utile/perdita netta:
$164.40M
Rapporto P/E:
70.04
EPS:
0.69
Flusso di cassa netto:
$236.51M
1 W Prestazione:
-5.48%
1M Prestazione:
+0.92%
6M Prestazione:
-18.33%
1 anno Prestazione:
+202.44%
Intervallo 1D:
$46.76
$48.65
Intervallo di 1 settimana:
$46.76
$53.53
Portata 52W:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Nome
Hims Hers Health Inc
Settore
Industria
Telefono
415-851-0195
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Confronta HIMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
48.33 | 11.30B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
155.41 | 363.02B | 84.28B | 15.97B | 14.04B | 6.51 |
|
UL
Unilever Plc Adr
|
62.44 | 149.32B | 65.76B | 6.16B | 0 | 2.4843 |
|
CL
Colgate Palmolive Co
|
86.34 | 68.25B | 20.00B | 2.91B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
134.81 | 44.51B | 18.88B | 2.43B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
21.71 | 40.72B | 15.30B | 1.06B | 1.45B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-23 | Downgrade | Needham | Buy → Hold |
| 2025-06-04 | Reiterato | Needham | Buy |
| 2025-04-29 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Downgrade | Citigroup | Neutral → Sell |
| 2025-01-07 | Iniziato | BTIG Research | Buy |
| 2024-12-17 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-08-22 | Iniziato | Needham | Buy |
| 2024-08-09 | Downgrade | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-04-16 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-02-28 | Aggiornamento | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | Imperial Capital | In-line |
| 2023-07-28 | Iniziato | TD Cowen | Outperform |
| 2023-04-11 | Iniziato | Robert W. Baird | Neutral |
| 2023-02-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-08 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-07-15 | Iniziato | SVB Leerink | Underperform |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-10 | Iniziato | Deutsche Bank | Hold |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-11-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Iniziato | BofA Securities | Neutral |
| 2021-05-20 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Iniziato | Truist | Hold |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-03-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Iniziato | Citigroup | Neutral |
| 2021-02-12 | Iniziato | Piper Sandler | Neutral |
| 2021-02-08 | Iniziato | Tigress Financial | Buy |
Mostra tutto
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
The Gross Law Firm Announces the Filing of a Securities - GlobeNewswire
Hedge Fund and Insider Trading News: George Soros, Dan Loeb, Lee Ainslie, Warren Buffett, Millennium Management, Discovery Capital Management, Sculptor Capital, Warner Bros Discovery Inc (WBD), Hims & Hers Health Inc (HIMS), and More - Insider Monkey
Hims & Hers (HIMS) Falls as Key Executives Dispose Shares - Insider Monkey
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? - TradingView
HIMS 2-WEEK DEADLINE ALERT: HIMS Shares Decline Amid Lower - GlobeNewswire
SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS) - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - FinancialContent
The Top 5 Analyst Questions From Hims & Hers Health’s Q2 Earnings Call - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Trading Down 4.1% Following Insider Selling - Defense World
Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
HIMS Q2 Deep Dive: International Expansion and Product Shifts Define Next Growth Phase - uk.finance.yahoo.com
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire
Hims CEO Reports $33 Million Sale in Largest Insider Trade - Bloomberg.com
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today - Yahoo Finance
Hims & Hers CEO sells $33 million in stock after a massive rally - MarketWatch
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Morningstar
Hims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now - inkl
DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law - GlobeNewswire
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care - Yahoo Finance
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Hims & Hers Health CEO discloses sale of over $33M worth of company stock - MSN
Hims & Hers Health stock down on CEO insider sale (HIMS:NYSE) - Seeking Alpha
HIMS Deadline Approaching on August 25, 2025: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Class Action Lawsuit Deadline | FinancialContent - FinancialContent
Lost Money on Hims & Hers Health, Inc. (HIMS)? Urged to Join Class Action Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
HIMS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Hims & Hers Health, Inc. – August 25, 2025 Deadline - ACCESS Newswire
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
HIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers - GlobeNewswire
Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 - ACCESS Newswire
Why is Novo Nordisk excluding Hims & Hers in its lawsuits over Wegovy copies? - Fast Company
Novo ramps up lawsuits over Wegovy copiesbut not for Hims & Hers - Yahoo Finance
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? - Yahoo Finance
Lost Money on Hims & Hers Health, Inc.(HIMS)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - Morningstar
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims? - Yahoo Finance
Hims & Hers Shares Plunge. Is This a Buying Opportunity or Should Investors Run for the Hills? - The Globe and Mail
Healthcare Stocks To Research – August 8th - Defense World
Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
Why Hims & Hers Stock Sank This Week - Mitrade
Where Will Hims & Hers Be in 5 Years? - The Globe and Mail
Best Healthcare Stocks To Add to Your Watchlist – August 7th - Defense World
Best Medical Stocks To Watch Now – August 7th - Defense World
Top Executive Sells Massive Stake in Hims & Hers Health! - TipRanks
HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Class Action Lawsuit Filed: Hims & Hers Health, Inc. (HIMS)Join by August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
HIMS and the Legal Reckoning in Telehealth: Navigating the Risks of Rapid Growth in a Regulated Sector - AInvest
HIMS FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, - GlobeNewswire
DEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Morningstar
Hims Stock Gets Booted Off IBD 50 While Other Volatile Names Hang On - Investor's Business Daily
HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 - GlobeNewswire
Hims Hers Health Inc Azioni (HIMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.28%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):